Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1161

1.

Advances in the treatment of hepatitis C.

Lawrence SP.

Adv Intern Med. 2000;45:65-105. Review.

PMID:
10635046
2.

Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.

Seeff LB, Hoofnagle JH.

Clin Liver Dis. 2003 Feb;7(1):261-87. Review.

PMID:
12691470
3.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
4.

Management issues in chronic viral hepatitis: hepatitis C.

Sievert W.

J Gastroenterol Hepatol. 2002 Apr;17(4):415-22. Review.

PMID:
11982722
5.

Projecting future complications of chronic hepatitis C in the United States.

Davis GL, Albright JE, Cook SF, Rosenberg DM.

Liver Transpl. 2003 Apr;9(4):331-8.

6.

Treatment of chronic hepatitis C in Asia: when East meets West.

Yu ML, Chuang WL.

J Gastroenterol Hepatol. 2009 Mar;24(3):336-45. doi: 10.1111/j.1440-1746.2009.05789.x. Review.

PMID:
19335784
7.

[Retreatment of patients with chronic hepatitis C].

Ostojić R.

Acta Med Croatica. 2005;59(5):447-51. Croatian.

PMID:
16381242
9.

Chronic hepatitis C virus infection in renal transplant: treatment and outcome.

Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.

Clin Transplant. 2006 Nov-Dec;20(6):677-83.

PMID:
17100715
10.

Natural history of hepatitis C.

Alberti A, Chemello L, Benvegnù L.

J Hepatol. 1999;31 Suppl 1:17-24. Review.

PMID:
10622555
11.

Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.

Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR.

Liver Transpl. 2004 Feb;10(2):199-207.

12.

Treatment of chronic hepatitis C virus infection - Dutch national guidelines.

de Bruijne J, Buster EH, Gelderblom HC, Brouwer JT, de Knegt RJ, van Erpecum KJ, Schalm SW, Bakker CM, Zaaijer HL, Janssen HL, Reesink HW; Netherlands Association of Gastroenterologists and Hepatologists.

Neth J Med. 2008 Jul-Aug;66(7):311-22. Review. Erratum in: Neth J Med. 2008 Dec;66(11):456. Dosage error in article text.

13.

Update on chronic hepatitis C in HIV/HCV-coinfected patients: viral interactions and therapy.

Bräu N.

AIDS. 2003 Nov 7;17(16):2279-90. Review. Erratum in: AIDS. 2004 Jan 2;18(1):135.

PMID:
14571179
14.

Ribavirin in the treatment of hepatitis C.

Abonyi ME, Lakatos PL.

Anticancer Res. 2005 Mar-Apr;25(2B):1315-20.

15.

Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.

Antúnez I, Aponte N, Fernández-Carbia A, Rodríguez-Perez F, Toro DH.

P R Health Sci J. 2004 Jun;23(2 Suppl):57-60.

PMID:
16929588
16.

Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.

Di Bisceglie AM, Thompson J, Smith-Wilkaitis N, Brunt EM, Bacon BR.

Hepatology. 2001 Mar;33(3):704-7.

PMID:
11230751
17.

Therapy of hepatitis C: patients with cirrhosis.

Schalm SW, Fattovich G, Brouwer JT.

Hepatology. 1997 Sep;26(3 Suppl 1):128S-132S. Review.

PMID:
9305677
18.

Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.

Bruno S, Zuin M, Crosignani A, Rossi S, Zadra F, Roffi L, Borzio M, Redaelli A, Chiesa A, Silini EM, Almasio PL, Maisonneuve P.

Am J Gastroenterol. 2009 May;104(5):1147-58. doi: 10.1038/ajg.2009.31. Epub 2009 Apr 7.

PMID:
19352340
19.

Hepatitis C.

Burra P.

Semin Liver Dis. 2009 Feb;29(1):53-65. doi: 10.1055/s-0029-1192055. Epub 2009 Feb 23. Review.

PMID:
19235659
20.

Supplemental Content

Support Center